Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway

Proteins targeted to the secretory pathway start their intracellular journey by being transported across biological membranes such as the endoplasmic reticulum (ER). A central component in this protein translocation process across the ER is the Sec61 translocon complex, which is only intracellularly...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eva Pauwels, Ralf Schülein, Kurt Vermeire
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/adcbc969cd514f42adfb7fd09346c4e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:adcbc969cd514f42adfb7fd09346c4e8
record_format dspace
spelling oai:doaj.org-article:adcbc969cd514f42adfb7fd09346c4e82021-11-11T17:25:37ZInhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway10.3390/ijms2221120071422-00671661-6596https://doaj.org/article/adcbc969cd514f42adfb7fd09346c4e82021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/12007https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Proteins targeted to the secretory pathway start their intracellular journey by being transported across biological membranes such as the endoplasmic reticulum (ER). A central component in this protein translocation process across the ER is the Sec61 translocon complex, which is only intracellularly expressed and does not have any enzymatic activity. In addition, Sec61 translocon complexes are difficult to purify and to reconstitute. Screening for small molecule inhibitors impairing its function has thus been notoriously difficult. However, such translocation inhibitors may not only be valuable tools for cell biology, but may also represent novel anticancer drugs, given that cancer cells heavily depend on efficient protein translocation into the ER to support their fast growth. In this review, different inhibitors of protein translocation will be discussed, and their specific mode of action will be compared. In addition, recently published screening strategies for small molecule inhibitors targeting the whole SRP-Sec61 targeting/translocation pathway will be summarized. Of note, slightly modified assays may be used in the future to screen for substances affecting SecYEG, the bacterial ortholog of the Sec61 complex, in order to identify novel antibiotic drugs.Eva PauwelsRalf SchüleinKurt VermeireMDPI AGarticlesignal recognition particle dependent protein targetingSec61 dependent translocationco-translational translocationendoplasmic reticuluminhibitorhigh throughput screeningBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12007, p 12007 (2021)
institution DOAJ
collection DOAJ
language EN
topic signal recognition particle dependent protein targeting
Sec61 dependent translocation
co-translational translocation
endoplasmic reticulum
inhibitor
high throughput screening
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle signal recognition particle dependent protein targeting
Sec61 dependent translocation
co-translational translocation
endoplasmic reticulum
inhibitor
high throughput screening
Biology (General)
QH301-705.5
Chemistry
QD1-999
Eva Pauwels
Ralf Schülein
Kurt Vermeire
Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
description Proteins targeted to the secretory pathway start their intracellular journey by being transported across biological membranes such as the endoplasmic reticulum (ER). A central component in this protein translocation process across the ER is the Sec61 translocon complex, which is only intracellularly expressed and does not have any enzymatic activity. In addition, Sec61 translocon complexes are difficult to purify and to reconstitute. Screening for small molecule inhibitors impairing its function has thus been notoriously difficult. However, such translocation inhibitors may not only be valuable tools for cell biology, but may also represent novel anticancer drugs, given that cancer cells heavily depend on efficient protein translocation into the ER to support their fast growth. In this review, different inhibitors of protein translocation will be discussed, and their specific mode of action will be compared. In addition, recently published screening strategies for small molecule inhibitors targeting the whole SRP-Sec61 targeting/translocation pathway will be summarized. Of note, slightly modified assays may be used in the future to screen for substances affecting SecYEG, the bacterial ortholog of the Sec61 complex, in order to identify novel antibiotic drugs.
format article
author Eva Pauwels
Ralf Schülein
Kurt Vermeire
author_facet Eva Pauwels
Ralf Schülein
Kurt Vermeire
author_sort Eva Pauwels
title Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
title_short Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
title_full Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
title_fullStr Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
title_full_unstemmed Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
title_sort inhibitors of the sec61 complex and novel high throughput screening strategies to target the protein translocation pathway
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/adcbc969cd514f42adfb7fd09346c4e8
work_keys_str_mv AT evapauwels inhibitorsofthesec61complexandnovelhighthroughputscreeningstrategiestotargettheproteintranslocationpathway
AT ralfschulein inhibitorsofthesec61complexandnovelhighthroughputscreeningstrategiestotargettheproteintranslocationpathway
AT kurtvermeire inhibitorsofthesec61complexandnovelhighthroughputscreeningstrategiestotargettheproteintranslocationpathway
_version_ 1718432138941956096